(Q43257046)

English

The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects

scientific article published on 22 October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Bo Tan

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Yi-Fan Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Xiao-Yan Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Xiao-Hua Zhao

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Guo-Xin Li

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Da-Fang Zhong

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

22 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

145-151

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapy for the treatment of patients with type 2 diabetes mellitus: rationale and specific agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the pharmacokinetics of glipizide and glibenclamide in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism and Kinetics of the Hypoglycemic Agent Glipizide in Man—Comparison with Glibenclamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of CYP2C9 genotype on warfarin dose requirements--a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP2C9 allelic variants: ethnic distribution and functional significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Simultaneous determination of metformin and glipizide in human plasma by liquid chromatography-tandem mass spectrometry].

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19847408

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-009-0736-2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43257046&oldid=2205913255"